|
Volumn 80, Issue 2-3, 2001, Pages 179-183
|
QT interval effects of cisapride in the clinical setting
|
Author keywords
Arrhythmia; Cisapride; QT interval
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
CISAPRIDE;
DILTIAZEM;
DIURETIC AGENT;
IMIDAZOLE;
LAXATIVE;
MACROLIDE;
NEUROLEPTIC AGENT;
TRICYCLIC ANTIDEPRESSANT AGENT;
ABDOMINAL DISCOMFORT;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DOSE RESPONSE;
DRUG CLEARANCE;
DRUG EFFECT;
DUODENUM ULCER;
ELECTROCARDIOGRAM;
FEMALE;
GASTROESOPHAGEAL REFLUX;
HEART ARRHYTHMIA;
HEART CONDUCTION;
HEART VENTRICLE TACHYCARDIA;
HOLTER MONITORING;
HOMEOSTASIS;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
QT INTERVAL;
STOMACH PARESIS;
STOMACH ULCER;
SYNCOPE;
TORSADE DES POINTES;
ADULT;
AGED;
AGED, 80 AND OVER;
BENZAMIDES;
CISAPRIDE;
ELECTROCARDIOGRAPHY;
FEMALE;
GASTROINTESTINAL AGENTS;
GASTROINTESTINAL DISEASES;
HEART;
HUMANS;
LONG QT SYNDROME;
MALE;
MIDDLE AGED;
OBSERVER VARIATION;
PROSPECTIVE STUDIES;
|
EID: 0034813856
PISSN: 01675273
EISSN: None
Source Type: Journal
DOI: 10.1016/S0167-5273(01)00485-5 Document Type: Article |
Times cited : (34)
|
References (16)
|